logo

For the Inventor, By the Inventor

Hacienda Heights, CA, United States of America

Rama Natarajan

This inventor holds 9 USPTO granted patents and 2 published patent applications. Top assignee: Beckman Research Institute, City of Hope. Active years: 2000-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rama Natarajan. Retrieved from https://idiyas.com/inventor/rama-natarajan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Hacienta Heights, CA (US) (2000 - 2002)
  • Duarte, CA (US) (2020)
  • Hacienda Heights, CA (US) (2001 - 2024)

Company Filing History:

goldMedal9 out of 692 
 
Beckman Research Institute, City of Hope
 patents

Years Active: 2000-2024

Loading Chart...
9 patents (USPTO):Explore Patents
1. 11974990 - TXNIP-TRX complex inhibitors and methods of using the same (2024-05-07),
2. 11964984 - TXNIP-TRX complex inhibitors and methods of using the same (2024-04-23),
3. 11324731 - TXNIP-TRX complex inhibitors and methods of using the same (2022-05-10),
4. 10787664 - Compounds of chemically modified oligonucleotides and methods of use thereof (2020-09-29),
5. 8580854 - Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitors (2013-11-12),
6. 6893829 - Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states (2005-05-17),
7. 6486181 - Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states (2002-11-26),
8. 6191169 - Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states (2001-02-20),
9. 6046224 - 12 (S)--hete receptor blockers (2000-04-04),

Title: Innovations of Rama Natarajan

Introduction

Rama Natarajan is a prominent inventor based in Hacienda Heights, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of inhibitors for the TXNIP-TRX complex. With a total of 9 patents to his name, Natarajan's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents, Natarajan has disclosed compounds and methods for inhibiting the thioredoxin-thioredoxin-interacting-protein (TXNIP-TRX) complex. This innovative approach aims to provide new avenues for treatment in related medical conditions. The details of these patents highlight the importance of his research in advancing therapeutic strategies.

Career Highlights

Natarajan is affiliated with City of Hope, a leading research and treatment center. His work there has allowed him to focus on groundbreaking research that addresses critical health challenges. His dedication to innovation in the field of biotechnology is evident through his numerous patents and ongoing research efforts.

Collaborations

Throughout his career, Natarajan has collaborated with esteemed colleagues, including Jerry L. Nadler and Feng Miao. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Rama Natarajan's contributions to the field of biotechnology through his patents and research at City of Hope exemplify the spirit of innovation. His work on TXNIP-TRX complex inhibitors showcases the potential for significant advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…